Advertisement

Presynaptic Modulation by Norepinephrine and Dopamine of Acetylcholine Release in the Peripheral and Central Nervous System

  • E. S. Vizi
  • A. Ronai
  • L. G. HarsingJr.
  • J. Knoll
Part of the Advances in Behavioral Biology book series (ABBI, volume 24)

Abstract

Discussion on the mode of action of psychoactive drugs are often based on the changes in brain monoamine content, although any change in content induced by a drug is not necessarily the best indicator of its mechanism of action. Electrophysiological methods, by which the receptors of central neuron for biogenic amines may be characterized as to location and function, still fail to provide convincing evidence of the mode of action of biogenic amines. With these techniques the most commonly observed action of norepinephrine (NE) in most parts of the central nervous system is depression of firing (7, 27–29). Although the typical actions of neurotransmitters on cell excitability in most regions of the neural axis have been described, relatively less information is available on the underlying mechanisms. In the last few years, however, neurochemical evidence has also been obtained concerning the pre- and post-synaptic action of different neurotransmitters in the CNS.

Keywords

Nerve Terminal Biogenic Amine Field Stimulation Presynaptic Inhibition Paralytic Ileus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andersen, P. and Curtis, D.R. (1964): Acta Physiol. Scand. 61: 100–120.PubMedCrossRefGoogle Scholar
  2. 2.
    Barbeau, A. (1975): Canad. J. Neurol. Sci. 2:81–85.Google Scholar
  3. 3.
    Beani, L., Bianchi, B., Clementina, C. and Crema, A. (1969): Brit. J. Pharmacol. 36:1–17.Google Scholar
  4. 4.
    Birkmayer, W. and Hornykiewicz, O. (1961): Wien. Klin. Wsch. 73:787–788.Google Scholar
  5. 5.
    Biscoe, T.J. and Straughan, D.W. (1966): J. Physiol. (Lond.) 183: 341–359.Google Scholar
  6. 6.
    Bloom, F. E., Oliver, A. P. and Salmoiraghi, G. C. (1973): Int. J. Neuropharmacol. 2:181–193.Google Scholar
  7. 7.
    Bloom, F.E. (1975): In: Handbook of Psychopharmacology, Vol.6, Biogenic Amine Receptors, (Eds.) L.L. Iversen, S.D. Iversen and S. H. Snyder, Plenum Press, New York, pp. 1–61.Google Scholar
  8. 8.
    Christ, D.D. and Nishi, S. (1971): J. Physiol. (Lond.) 213:107–117.Google Scholar
  9. 9.
    Costall, B., Naylor, R.J. and Pycock, C. (1976): Eur. J. Pharmacol. 35:275–283.CrossRefGoogle Scholar
  10. 10.
    Dawes, P.M. and Vizi, E.S. (1973): Brit. J. Pharmacol. 48:225–232.Google Scholar
  11. 11.
    Fibiger, H. C. and Grewaal, D.S. (1974): Life Sci. 15:57–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Furness, J.B. and Costa, M. (1974): Physiol. Rev. 69:1–51.Google Scholar
  13. 13.
    Fuxe, K., Hokfelt, T. and Nilsson, O. (1964): Z. Zellforsch. Histochem. 63:701.Google Scholar
  14. 14.
    Fuxe, K., Hamberger, B. and Hokfelt, T. (1964): Brain Res. 8: 125–131.CrossRefGoogle Scholar
  15. 15.
    Greengard, P. and McAffee, D.A. (1972): Biochem. Soc. Symp. 36:87–102.Google Scholar
  16. 16.
    Guyenet, P. G., Agid, Y., Javoy, F., Beaujouan, J. C., Rossier, J. and Glowinski, J. (1975): Brain Res. 84:227–244.PubMedCrossRefGoogle Scholar
  17. 17.
    Jones, B.E., Guyenet, P., Cheramy, A., Gauchy, C. and Glowinski, J. (1973): Brain Res. 64:355–369.PubMedCrossRefGoogle Scholar
  18. 18.
    Klawans, H. L. Jr. (1970): Eur. Neurol. 4:148–163.PubMedCrossRefGoogle Scholar
  19. 19.
    Knoll, J. and Vizi, E.S. (1970): Brit. J. Pharmacol. 40:554–555.Google Scholar
  20. 20.
    Knoll, J. and Vizi, E.S. (1971): Brit. J. Pharmacol. 42:263–272.Google Scholar
  21. 21.
    Kosterlitz, H.W., Lyden, R.J. and Watt, A.J. (1970): Brit. J. Pharmacol. 39:398–413.Google Scholar
  22. 22.
    McKenzie, G.M. and Viik, K. (1975): Exp. Neurol. 46:229–243.PubMedCrossRefGoogle Scholar
  23. 23.
    McLennan, H. and York, D.H. (1966): J. Physiol. (Lond.) 187:163–175.Google Scholar
  24. 24.
    Paton, W.D. and Vizi, E.S. (1969): Brit. J. Pharmacol. 35:10–28.Google Scholar
  25. 25.
    Perry, T.L., Hansen, S. and Kloster, M. (1973): New Eng. J.Med. 288:337–342.PubMedCrossRefGoogle Scholar
  26. 26.
    Petri, G., Szenohradszky, J. and Porszasz-Gibiszer, K. (1971): Surgery 70:359–367.PubMedGoogle Scholar
  27. 27.
    Phillis, J.W. and Kostopoulus, G.K. (1976): Life Sci. 17:1085–1094.CrossRefGoogle Scholar
  28. 28.
    Phillis, J.W. (1976): In: Taurine, (Eds.) R. Huxtable and A. Barbeau, Raven Press, New York, pp. 209–223.Google Scholar
  29. 29.
    Phillis, J.W., Tebecis, A.K. and York, D.H. (1968): Eur. J. Pharmacol. 1:471–475.CrossRefGoogle Scholar
  30. 30.
    Stadler, H., Lloyd, K., Gadea-Ciria, K.G. and Bartholini, G. (1973): Brain Res. 55:476–480.PubMedCrossRefGoogle Scholar
  31. 31.
    Trabucchi, M., Cheney, D., Racagni, G. and Costa, E. (1974): Nature 249:664–666.PubMedCrossRefGoogle Scholar
  32. 32.
    Vizi, E.S. (1968): Arch. Pharmacol. 259:199–200.Google Scholar
  33. 33.
    Vizi, E.S. and Knoll, J. (1971): J. Pharm. Pharmacol. 23:918–925.Google Scholar
  34. 34.
    Vizi, E.S. (1972): J. Physiol. (Lond.) 226:95–117.Google Scholar
  35. 35.
    Vizi, E.S. (1973): Brit. J. Pharmacol. 47:765–777.Google Scholar
  36. 36.
    Vizi, E.S., Ronai, A. and Knoll, J. (1974): N.-S. Arch. Pharmacol. Suppl. 285:R89.Google Scholar
  37. 37.
    Vizi, E.S. (1974): J. Neural Trans. Suppl. 11:61–78.Google Scholar
  38. 38.
    Vizi, E.S. (1975): In: Subcortical Mechanisms and Sensorimotor Activities (Ed.) T.L. Friggesi, Hans Huber, Bern, pp.63–87.Google Scholar
  39. 39.
    Vizi, E.S. (1976): In: Physiology of Smooth Muscle, (Eds.) E. Bulbring and M. F. Shuba, Raven Press, New York, pp. 357–367.Google Scholar
  40. 40.
    Vizi, E.S., Ronai, A., Harsing, L.G. Jr. and Knoll, J. (1977): Polish J. Pharmacol. (in press).Google Scholar
  41. 41.
    Westfall, T. C., Besson, M.J., Giorguieff, M.F. and Glowinski, J. (1976): N.-S. Arch. Pharmacol. 292:279–287.CrossRefGoogle Scholar
  42. 42.
    Wikberg, J. (1977): Acta Physiol. Scand. 99:190–207.PubMedCrossRefGoogle Scholar
  43. 43.
    York, D.H. (1970): Brain Res. 20:223–249.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • E. S. Vizi
    • 1
  • A. Ronai
    • 1
  • L. G. HarsingJr.
    • 1
  • J. Knoll
    • 1
  1. 1.Department of PharmacologySemmelweis University of MedicineBudapestHungary

Personalised recommendations